Access the full text.
Sign up today, get DeepDyve free for 14 days.
(2014)
Low-grade gliomas: dynamic susceptiAJNR
N. Sadeghi, N. D’haene, C. Decaestecker, M. Levivier, T. Metens, C. Maris, D. Wikler, D. Baleriaux, I. Salmon, S. Goldman (2008)
Apparent Diffusion Coefficient and Cerebral Blood Volume in Brain Gliomas: Relation to Tumor Cell Density and Tumor Microvessel Density Based on Stereotactic BiopsiesAmerican Journal of Neuroradiology, 29
S. Saraswathy, Forrest Crawford, K. Lamborn, A. Pirzkall, Susan Chang, S. Cha, S. Nelson (2008)
Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapyJournal of Neuro-Oncology, 91
W. Pope, A. Lai, R. Mehta, Hyun Kim, J. Qiao, J. Young, X. Xue, Jonathan Goldin, Matthew Brown, P. Nghiemphu, A. Tran, T. Cloughesy (2011)
Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated GlioblastomaAmerican Journal of Neuroradiology, 32
M. Law, Sarah Oh, J. Babb, E. Wang, M. Inglese, D. Zagzag, E. Knopp, G. Johnson (2006)
Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.Radiology, 238 2
M. Law, Stanley Yang, J. Babb, E. Knopp, J. Golfinos, D. Zagzag, G. Johnson (2004)
Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.AJNR. American journal of neuroradiology, 25 5
M. Jansen, S. Yip, D. Louis (2010)
Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markersThe Lancet Neurology, 9
K. Kono, Y. Inoue, K. Nakayama, M. Shakudo, M. Morino, K. Ohata, K. Wakasa, R. Yamada (2001)
The role of diffusion-weighted imaging in patients with brain tumors.AJNR. American journal of neuroradiology, 22 6
F Harrell, Kerry Lee, D. Mark (2005)
Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors
F. Ducray, Y. Marie, M. Sanson (2009)
IDH1 and IDH2 mutations in gliomas.The New England journal of medicine, 360 21
Meng Law, Robert Young, James Babb, Erica Pollack, Glyn Johnson (2007)
Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas.AJNR. American journal of neuroradiology, 28 4
E. Paulson, K. Schmainda (2008)
Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.Radiology, 249 2
S. Wetzel, S. Cha, G. Johnson, Peter Lee, M. Law, D. Kasow, Sean Pierce, X. Xue (2002)
Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study.Radiology, 224 3
M. Labussière, Xiao-wei Wang, A. Idbaih, F. Ducray, M. Sanson (2010)
Prognostic markers in gliomas.Future oncology, 6 5
I. Caroline, M. Rosenthal, M. Rosenthal (2012)
Imaging modalities in high-grade gliomas: Pseudoprogression, recurrence, or necrosis?Journal of Clinical Neuroscience, 19
J. Boxerman, D. Prah, Eric Paulson, J. Machan, D. Bedekar, K. Schmainda (2012)
The Role of Preload and Leakage Correction in Gadolinium-Based Cerebral Blood Volume Estimation Determined by Comparison with MION as a Criterion StandardAmerican Journal of Neuroradiology, 33
R. Newson (2006)
Confidence Intervals for Rank Statistics: Somers’ D and ExtensionsThe Stata Journal, 6
M. Law, R. Young, J. Babb, N. Peccerelli, S. Chheang, M. Gruber, Douglas Miller, J. Golfinos, D. Zagzag, G. Johnson (2008)
Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.Radiology, 247 2
B. Hakyemez, C. Erdoğan, I. Ercan, Necdet Ergin, S. Uysal, S. Atahan (2005)
High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.Clinical radiology, 60 4
F. Ducray, S. Hallani, A. Idbaih (2009)
Diagnostic and prognostic markers in gliomasCurrent Opinion in Oncology, 21
Louis N, Ohgaki H, Cavenee K (1982)
The classification of tumours of the central nervous system.Neuropathology and applied neurobiology, 8 1
Theeler Bj, Yung Wk, Gn Fuller, De Groot, Jf (2012)
Moving toward molecular classification of diffuse gliomas in adultsNeurology, 79
T. Sugahara, Y. Korogi, M. Kochi, I. Ikushima, Y. Shigematu, T. Hirai, T. Okuda, L. Liang, Y. Ge, Y. Komohara, Yukitaka Ushio, Mutsumasa Takahashi (1999)
Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomasJournal of Magnetic Resonance Imaging, 9
E. Zacharaki, N. Morita, P. Bhatt, D. O’Rourke, E. Melhem, C. Davatzikos (2012)
Survival Analysis of Patients with High-Grade Gliomas Based on Data Mining of Imaging VariablesAmerican Journal of Neuroradiology, 33
M. Bondy, M. Scheurer, B. Malmer, J. Barnholtz-Sloan, Faith Davis, D. Il’yasova, C. Kruchko, B. McCarthy, P. Rajaraman, J. Schwartzbaum, S. Sadetzki, B. Schlehofer, T. Tihan, J. Wiemels, M. Wrensch, P. Buffler (2008)
Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology ConsortiumCancer, 113
D. Louis, H. Ohgaki, O. Wiestler, W. Cavenee, P. Burger, A. Jouvet, B. Scheithauer, P. Kleihues (2007)
The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 114
W. Pope, Xin Qiao, Hyun Kim, A. Lai, P. Nghiemphu, X. Xue, B. Ellingson, D. Schiff, D. Aregawi, S. Cha, V. Puduvalli, Jing Wu, W. Yung, G. Young, J. Vredenburgh, D. Barboriak, L. Abrey, T. Mikkelsen, R. Jain, N. Paleologos, P. Rn, M. Prados, J. Goldin, P. Wen, T. Cloughesy (2012)
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center studyJournal of Neuro-Oncology, 108
Saulo Lacerda, M. Law (2009)
Magnetic resonance perfusion and permeability imaging in brain tumors.Neuroimaging clinics of North America, 19 4
D. Hardesty, N. Sanai (2012)
The Value of Glioma Extent of Resection in the Modern Neurosurgical EraFrontiers in Neurology, 3
S. Cha (2006)
Update on brain tumor imaging: from anatomy to physiology.AJNR. American journal of neuroradiology, 27 3
L. D. (2005)
Brain tumorsPsychiatric Quarterly, 4
A. Hilario, A. Ramos, Á. Pérez-Núñez, E. Salvador, J. Millán, A. Lagares, J. Sepúlveda, P. González-León, A. Hernández-Laín, J. Ricoy (2012)
The Added Value of Apparent Diffusion Coefficient to Cerebral Blood Volume in the Preoperative Grading of Diffuse GliomasAmerican Journal of Neuroradiology, 33
D. Hamstra, T. Chenevert, B. Moffat, T. Johnson, C. Meyer, S. Mukherji, D. Quint, S. Gebarski, Xiaoying Fan, C. Tsien, T. Lawrence, L. Junck, A. Rehemtulla, B. Ross (2005)
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma.Proceedings of the National Academy of Sciences of the United States of America, 102 46
BACKGROUND AND PURPOSE: Diffuse gliomas are classified as grades II–IV on the basis of histologic features, with prognosis determined mainly by clinical factors and histologic grade supported by molecular markers. Our aim was to evaluate, in patients with diffuse gliomas, the relationship of relative CBV and ADC values to overall survival. In addition, we also propose a prognostic model based on preoperative MR imaging findings that predicts survival independent of histopathology. MATERIALS AND METHODS: We conducted a retrospective analysis of the preoperative diffusion and perfusion MR imaging in 126 histologically confirmed diffuse gliomas. Median relative CBV and ADC values were selected for quantitative analysis. Survival univariate analysis was made by constructing survival curves by using the Kaplan-Meier method and comparing subgroups by log-rank probability tests. A Cox regression model was made for multivariate analysis. RESULTS: The study included 126 diffuse gliomas (median follow-up of 14.5 months). ADC and relative CBV values had a significant influence on overall survival. Median overall survival for patients with ADC < 0.799 × 10 −3 mm 2 /s was <1 year. Multivariate analysis revealed that patient age, relative CBV, and ADC values were associated with survival independent of pathology. The preoperative model provides greater ability to predict survival than that obtained by histologic grade alone. CONCLUSIONS: ADC values had a better correlation with overall survival than relative CBV values. A preoperative prognostic model based on patient age, relative CBV, and ADC values predicted overall survival of patients with diffuse gliomas independent of pathology. This preoperative model provides a more accurate predictor of survival than histologic grade alone. ABBREVIATION: rCBV relative cerebral blood volume
American Journal of Neuroradiology – American Journal of Neuroradiology
Published: Jun 1, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.